Plasma transfusion is a life-saving intervention that replaces missing clotting factors, supports immune function, and restores blood volume after severe trauma or surgery. While generally safe when performed with rigorous screening and monitoring, plasma transfusion side effects can range from minor, self-limiting reactions to rare but severe complications that demand immediate clinical attention.
Common and Expected Reactions
Most plasma transfusion side effects fall into the category of mild, short-lived responses that resolve without long-term consequences. These include fever, chills, and mild itching, often tied to the body’s reaction to donor proteins or preservatives. Some patients experience transient swelling in the hands, face, or airway due to fluid shifts or mild allergic sensitivity, which typically subsides once the infusion rate is slowed or antihistamines are administered.
Managing Minor Symptoms
Clinical teams commonly manage these minor plasma transfusion side effects by temporarily stopping the transfusion, administering antihistamines or corticosteroids, and closely observing vital signs. Slowing the infusion rate can reduce the likelihood of fluid overload, especially in elderly patients or those with compromised kidney or heart function. Documenting these reactions helps clinicians adjust future transfusions to minimize discomfort and prevent escalation.
Allergic and Anaphylactic Reactions More serious plasma transfusion side effects involve allergic reactions, which occur when the recipient’s immune system overreacts to proteins in the donor plasma. Symptoms can include widespread hives, severe itching, wheezing, and a sudden drop in blood pressure. In rare cases, anaphylaxis develops rapidly, requiring immediate discontinuation of the transfusion, administration of epinephrine, and advanced airway support to prevent life-threatening complications. Transfusion-Related Acute Lung Injury
More serious plasma transfusion side effects involve allergic reactions, which occur when the recipient’s immune system overreacts to proteins in the donor plasma. Symptoms can include widespread hives, severe itching, wheezing, and a sudden drop in blood pressure. In rare cases, anaphylaxis develops rapidly, requiring immediate discontinuation of the transfusion, administration of epinephrine, and advanced airway support to prevent life-threatening complications.
Transfusion-Related Acute Lung Injury, or TRALI, represents one of the most dangerous plasma transfusion side effects, characterized by sudden respiratory distress, low blood oxygen levels, and pulmonary edema without an underlying heart condition. TRALI is believed to be triggered by antibodies from the donor plasma that activate the recipient’s white blood cells, causing inflammation and leakage in the lungs. Prompt recognition and intensive care support, including mechanical ventilation, are essential to reduce mortality risk.
Circulatory Overload and Metabolic Shifts
Patients receiving large or rapid volumes of plasma may experience circulatory overload, leading to shortness of breath, elevated blood pressure, and swelling in the legs or lungs. This risk is especially high in individuals with preexisting heart failure or kidney disease. Metabolic shifts, such as changes in calcium and electrolyte balance, can also occur, particularly when citrate, an anticoagulant used in plasma storage, binds calcium in the bloodstream and affects nerve and muscle function.
Rare Infectious and Immunological Risks
Although modern screening and pathogen reduction technologies have greatly minimized infectious risks, plasma transfusion side effects related to emerging or undetected pathogens remain a theoretical concern. These include transmission of viruses, bacteria, or prions if the donor is in the window period of infection or if screening protocols fail. Immunological complications, such as altered immune regulation or passive transfer of donor antibodies, may also influence recovery in transplant or critically ill patients, necessitating careful risk-benefit evaluation.
Prevention, Monitoring, and Clinical Best Practices
Minimizing plasma transfusion side effects begins with strict donor selection, comprehensive infectious disease testing, and adherence to evidence-based transfusion criteria. Clinicians should individualize transfusion strategies, considering patient comorbidities, hemodynamic status, and laboratory values. Continuous monitoring during and after the infusion, combined with clear protocols for managing reactions, ensures timely intervention and improves overall patient safety.
